Open AccessAntibacterial Susceptibility Testing of Cutibacterium acnes in Acne Vulgaris Patients
Author(s) -
Ingus Skadiņš,
Aleksejs Zavorins,
Juta Kroiča,
Terēze Pavloviča,
Dagnija Bruzgule,
Tatjana Averjanova
Publication year - 2021
Publication title -
clinical, cosmetic and investigational dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 35
ISSN - 1178-7015
DOI - 10.2147/ccid.s311624
Subject(s) - acne , propionibacterium acnes , dermatology , medicine , microbiology and biotechnology , biology
Combination therapy is widely used for the treatment of acne vulgaris (AV), including local anti-inflammatory drugs containing antimicrobials, such as clindamycin or erythromycin, to inhibit Cutibacterium acnes ( C. acnes ) growth and at the same time reduce the production of inflammatory mediators. The aim of the study is to compare the antibacterial susceptibility of C. acnes to clindamycin and erythromycin in AV patients compared with healthy patients in the control group (CG).